1. Home
  2. HALO vs FND Comparison

HALO vs FND Comparison

Compare HALO & FND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • FND
  • Stock Information
  • Founded
  • HALO 1998
  • FND 2000
  • Country
  • HALO United States
  • FND United States
  • Employees
  • HALO N/A
  • FND N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • FND RETAIL: Building Materials
  • Sector
  • HALO Health Care
  • FND Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • FND Nasdaq
  • Market Cap
  • HALO 7.4B
  • FND 7.9B
  • IPO Year
  • HALO N/A
  • FND 2017
  • Fundamental
  • Price
  • HALO $52.02
  • FND $79.54
  • Analyst Decision
  • HALO Buy
  • FND Hold
  • Analyst Count
  • HALO 9
  • FND 19
  • Target Price
  • HALO $63.56
  • FND $94.68
  • AVG Volume (30 Days)
  • HALO 3.1M
  • FND 2.6M
  • Earning Date
  • HALO 05-06-2025
  • FND 05-01-2025
  • Dividend Yield
  • HALO N/A
  • FND N/A
  • EPS Growth
  • HALO 55.40
  • FND N/A
  • EPS
  • HALO 3.76
  • FND 1.89
  • Revenue
  • HALO $1,084,306,000.00
  • FND $4,519,221,000.00
  • Revenue This Year
  • HALO $24.79
  • FND $7.59
  • Revenue Next Year
  • HALO $22.65
  • FND $10.93
  • P/E Ratio
  • HALO $13.83
  • FND $42.02
  • Revenue Growth
  • HALO 25.64
  • FND 2.96
  • 52 Week Low
  • HALO $41.28
  • FND $66.01
  • 52 Week High
  • HALO $70.51
  • FND $126.74
  • Technical
  • Relative Strength Index (RSI)
  • HALO 39.78
  • FND 56.15
  • Support Level
  • HALO $47.50
  • FND $72.78
  • Resistance Level
  • HALO $69.94
  • FND $86.23
  • Average True Range (ATR)
  • HALO 3.52
  • FND 2.62
  • MACD
  • HALO -1.49
  • FND 1.18
  • Stochastic Oscillator
  • HALO 19.64
  • FND 57.69

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About FND Floor & Decor Holdings Inc.

Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.

Share on Social Networks: